Astrana Health Inc (ASTH)
55.92
+1.62
(+2.98%)
USD |
NASDAQ |
Nov 05, 16:00
55.92
0.00 (0.00%)
After-Hours: 19:20
Astrana Health Revenue (Quarterly): 486.26M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 486.26M |
| March 31, 2024 | 404.36M |
| December 31, 2023 | 353.04M |
| September 30, 2023 | 348.17M |
| June 30, 2023 | 348.21M |
| March 31, 2023 | 337.24M |
| December 31, 2022 | 294.21M |
| September 30, 2022 | 317.00M |
| June 30, 2022 | 269.70M |
| March 31, 2022 | 263.26M |
| December 31, 2021 | 195.10M |
| September 30, 2021 | 227.12M |
| June 30, 2021 | 175.64M |
| March 31, 2021 | 176.06M |
| December 31, 2020 | -140.15M |
| September 30, 2020 | 180.12M |
| June 30, 2020 | 165.17M |
| March 31, 2020 | 165.10M |
| December 31, 2019 | 178.75M |
| September 30, 2019 | 156.06M |
| June 30, 2019 | 130.05M |
| March 31, 2019 | 95.76M |
| December 31, 2018 | 105.46M |
| September 30, 2018 | 167.28M |
| June 30, 2018 | 123.00M |
| Date | Value |
|---|---|
| March 31, 2018 | 124.17M |
| September 30, 2017 | 40.48M |
| June 30, 2017 | 41.58M |
| March 31, 2017 | 14.76M |
| December 31, 2016 | 15.67M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 12.37M |
| March 31, 2016 | 11.82M |
| December 31, 2015 | 10.66M |
| September 30, 2015 | 11.37M |
| June 30, 2015 | 10.20M |
| March 31, 2015 | 9.588M |
| December 31, 2014 | 7.642M |
| September 30, 2014 | 11.67M |
| June 30, 2014 | 4.094M |
| January 31, 2014 | 2.840M |
| October 31, 2013 | 2.605M |
| July 31, 2013 | 2.593M |
| April 30, 2013 | 2.447M |
| January 31, 2013 | 2.530M |
| October 31, 2012 | 1.965M |
| July 31, 2012 | 1.650M |
| April 30, 2012 | 1.632M |
| January 31, 2012 | 1.545M |
| October 31, 2011 | 1.432M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-140.15M
Minimum
Dec 2020
486.26M
Maximum
Jun 2024
249.70M
Average
263.26M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Evolent Health Inc | 647.14M |
| American Shared Hospital Services | 7.056M |
| Novo Integrated Sciences Inc | 3.152M |
| Cryo-Cell International Inc | 8.067M |
| P3 Health Partners Inc | 379.16M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.17M |
| Total Expenses (Quarterly) | 456.20M |
| EPS Diluted (Quarterly) | 0.40 |
| Enterprise Value | 2.392B |
| Gross Profit Margin (Quarterly) | 15.11% |
| Profit Margin (Quarterly) | 3.94% |
| Earnings Yield | 2.58% |
| Operating Earnings Yield | 3.60% |
| Normalized Earnings Yield | 2.520 |